330 related articles for article (PubMed ID: 11115818)
1. An exaggerated sensory component of the gastrocolonic response in patients with irritable bowel syndrome.
Simrén M; Abrahamsson H; Björnsson ES
Gut; 2001 Jan; 48(1):20-7. PubMed ID: 11115818
[TBL] [Abstract][Full Text] [Related]
2. Lipid-induced colonic hypersensitivity in the irritable bowel syndrome: the role of bowel habit, sex, and psychologic factors.
Simrén M; Abrahamsson H; Björnsson ES
Clin Gastroenterol Hepatol; 2007 Feb; 5(2):201-8. PubMed ID: 17174611
[TBL] [Abstract][Full Text] [Related]
3. Abnormal levels of neuropeptide Y and peptide YY in the colon in irritable bowel syndrome.
Simrén M; Stotzer PO; Sjövall H; Abrahamsson H; Björnsson ES
Eur J Gastroenterol Hepatol; 2003 Jan; 15(1):55-62. PubMed ID: 12544695
[TBL] [Abstract][Full Text] [Related]
4. Visceral sensitivity and symptoms in patients with constipation- or diarrhea-predominant irritable bowel syndrome (IBS): effect of a low-fat intraduodenal infusion.
Caldarella MP; Milano A; Laterza F; Sacco F; Balatsinou C; Lapenna D; Pierdomenico SD; Cuccurullo F; Neri M
Am J Gastroenterol; 2005 Feb; 100(2):383-9. PubMed ID: 15667496
[TBL] [Abstract][Full Text] [Related]
5. Lipid-induced colonic hypersensitivity in irritable bowel syndrome: the role of 5-HT3 receptors.
Simrén M; Simms L; D'Souza D; Abrahamsson H; Björnsson ES
Aliment Pharmacol Ther; 2003 Jan; 17(2):279-87. PubMed ID: 12534414
[TBL] [Abstract][Full Text] [Related]
6. Rectal afferent hypersensitivity and compliance in irritable bowel syndrome: differences between diarrhoea-predominant and constipation-predominant subgroups.
Zar S; Benson MJ; Kumar D
Eur J Gastroenterol Hepatol; 2006 Feb; 18(2):151-8. PubMed ID: 16394796
[TBL] [Abstract][Full Text] [Related]
7. [Role of gut hormones in irritable bowel syndrome].
Morise K; Furusawa A; Yamamoto H; Saito H
Nihon Rinsho; 1992 Nov; 50(11):2697-702. PubMed ID: 1287245
[TBL] [Abstract][Full Text] [Related]
8. Irritable bowel syndrome: physiological and psychological differences between diarrhea-predominant and constipation-predominant patients.
Whitehead WE; Engel BT; Schuster MM
Dig Dis Sci; 1980 Jun; 25(6):404-13. PubMed ID: 7379673
[TBL] [Abstract][Full Text] [Related]
9. Effect of a corticotropin releasing hormone receptor antagonist on colonic sensory and motor function in patients with irritable bowel syndrome.
Sagami Y; Shimada Y; Tayama J; Nomura T; Satake M; Endo Y; Shoji T; Karahashi K; Hongo M; Fukudo S
Gut; 2004 Jul; 53(7):958-64. PubMed ID: 15194643
[TBL] [Abstract][Full Text] [Related]
10. Compliance, tone and sensitivity of the rectum in different subtypes of irritable bowel syndrome.
Steens J; Van Der Schaar PJ; Penning C; Brussee J; Masclee AA
Neurogastroenterol Motil; 2002 Jun; 14(3):241-7. PubMed ID: 12061908
[TBL] [Abstract][Full Text] [Related]
11. Exaggerated motility of the descending colon with repetitive distention of the sigmoid colon in patients with irritable bowel syndrome.
Fukudo S; Kanazawa M; Kano M; Sagami Y; Endo Y; Utsumi A; Nomura T; Hongo M
J Gastroenterol; 2002 Nov; 37 Suppl 14():145-50. PubMed ID: 12572883
[TBL] [Abstract][Full Text] [Related]
12. Comparison of 5-hydroxytryptophan signaling pathway characteristics in diarrhea-predominant irritable bowel syndrome and ulcerative colitis.
Yu FY; Huang SG; Zhang HY; Ye H; Chi HG; Zou Y; Lv RX; Zheng XB
World J Gastroenterol; 2016 Mar; 22(12):3451-9. PubMed ID: 27022227
[TBL] [Abstract][Full Text] [Related]
13. Proximal and distal gut hormone secretion in irritable bowel syndrome.
Van Der Veek PP; Biemond I; Masclee AA
Scand J Gastroenterol; 2006 Feb; 41(2):170-7. PubMed ID: 16484122
[TBL] [Abstract][Full Text] [Related]
14. Correlation of gut hormones with irritable bowel syndrome.
Zhang H; Yan Y; Shi R; Lin Z; Wang M; Lin L
Digestion; 2008; 78(2-3):72-6. PubMed ID: 18948690
[TBL] [Abstract][Full Text] [Related]
15. Anorectal manometry in irritable bowel syndrome: differences between diarrhoea and constipation predominant subjects.
Prior A; Maxton DG; Whorwell PJ
Gut; 1990 Apr; 31(4):458-62. PubMed ID: 2338274
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of colonic sensory thresholds in IBS patients using a barostat. Definition of optimal conditions and comparison with healthy subjects.
Bradette M; Delvaux M; Staumont G; Fioramonti J; Bueno L; Frexinos J
Dig Dis Sci; 1994 Mar; 39(3):449-57. PubMed ID: 8131679
[TBL] [Abstract][Full Text] [Related]
17. Treatment with hypnotherapy reduces the sensory and motor component of the gastrocolonic response in irritable bowel syndrome.
Simrén M; Ringström G; Björnsson ES; Abrahamsson H
Psychosom Med; 2004; 66(2):233-8. PubMed ID: 15039508
[TBL] [Abstract][Full Text] [Related]
18. Disturbed motilin and cholecystokinin release in the irritable bowel syndrome.
Sjölund K; Ekman R; Lindgren S; Rehfeld JF
Scand J Gastroenterol; 1996 Nov; 31(11):1110-4. PubMed ID: 8938905
[TBL] [Abstract][Full Text] [Related]
19. Sigmoid afferent mechanisms in patients with irritable bowel syndrome.
Lembo T; Munakata J; Naliboff B; Fullerton S; Mayer EA
Dig Dis Sci; 1997 Jun; 42(6):1112-20. PubMed ID: 9201070
[TBL] [Abstract][Full Text] [Related]
20. [Irritable bowel syndrome with extraintestinal manifestations from a position of neuroendocrine pathology].
Osadchuk MA; Burdina VO
Eksp Klin Gastroenterol; 2015; (2):29-34. PubMed ID: 25993870
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
